Appointment Announcement – Jamie Moss, Executive Chair
TRI is delighted to announce the appointment of Jamie Moss as Executive Chair.
Jamie is a highly respected figure in the life sciences industry, with over three decades of leadership experience spanning enterprise software, clinical trial technology, and tech-enabled services. His career includes senior executive roles at global organisations such as Calyx (formerly Parexel Informatics), where he served as Group COO and CEO of Enterprise Technologies, and CRF Health, where he led global operations delivering patient-centric software solutions.
Jamie’s leadership has consistently driven commercial success, operational excellence, and innovation. At Calyx, he was instrumental in shaping strategy, strengthening governance, and executing a successful business separation. At CRF Health, his focus on delivery quality and client engagement supported double-digit growth and industry-leading employee satisfaction.
In addition to his executive experience, Jamie serves on the Finance Board of the Institution of Mechanical Engineers and is an Operating Partner at Pace Strategic Advisors. He is passionate about advancing clinical development through technology and now focuses on supporting innovative life sciences businesses to scale and grow.
His appointment signals a bold step forward for TRI as we continue to evolve and expand our capabilities in clinical trial execution. We are excited to have Jamie’s strategic guidance and industry insight as we enter this new chapter.
Interested in TRI?
Our mission, vision, and values are unified in a single goal, to simplify Risk-Based Quality Management (RBQM) for all clinical trials.
Find out where we started, and why we want to see RBQM not as a regulatory burden, but a standard practice embraced for its simplicity and effectiveness.